How does Parkinson’s disease contribute to healthcare expenditure in India?

March 25, 2025

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts


How does Parkinson’s disease contribute to healthcare expenditure in India?

Parkinson’s disease (PD) significantly contributes to the cost of healthcare in India because of the long-term and progressive nature of the disease, long-term care, and specialized care. As the number of people living with Parkinson’s disease is increasing, with a greater emphasis on aging population, the cost burden on the healthcare system is also mounting. Some of the following are the different ways through which Parkinson’s disease contributes to the cost of healthcare in India:

1. Diagnostic Cost
Neurological Specialty Care: Diagnosing Parkinson’s disease could entail the expertise of neurologists and specialists who are able to assess motor symptoms, cognitive function, and the rule out of other illness. The process could include diagnostic tests, imaging tests (e.g., MRIs), and neurological specialty testing, all of which come with a cost.

Long Delays in Diagnosis: In some areas of India, particularly rural areas, specialists may not be easily accessible, leading to delayed diagnosis and higher healthcare costs due to complications arising out of undiagnosed or untreated PD.

2. Cost of Medications
Long-Term Use of Medication: Parkinson’s disease is a life-long medication disorder, and levodopa and other dopaminergic drugs need to be used to manage symptoms. The drugs can be costly, especially for brand names, and patients may need to switch medication regimens after a few years as the disease progresses.

Availability and Affordability: While generic forms of drugs for Parkinson’s do exist in India, some may still lack access to quality and affordable drugs, leading to irregular treatment and high long-term costs of healthcare due to complications.

Side Effects Management: Side effects of drugs for Parkinson’s, such as dyskinesia or motor fluctuations, require other treatments or adjustment in the regimen, contributing to the total cost of healthcare.

3. Rehabilitation and Physical Therapy
Ongoing Physical Therapy Requirements: Motor function is significantly compromised by Parkinson’s disease, and patients typically require ongoing physical therapy, speech therapy, and occupational therapy to attain mobility, improve quality of life, and manage symptoms. The therapies may be costly, especially in the long run.

Lack of Specialized Centers: Few specialized Parkinson’s disease centers exist, and patients mostly need to travel a long distance for treatment, which involves additional travel and accommodation costs. Inadequate availability of trained therapists and support staff also raises the cost for patients who must undergo treatment from private clinics.

4. Hospital Admissions and Surgical Interventions
Hospitalization Cost: In late Parkinson’s disease, patients are likely to acquire serious complications such as swallowing dysfunctions, falls, or other neurological issues and may require hospitalization. The prolonged hospitalization can be an expensive burden for healthcare.

Surgical Alternatives: Deep brain stimulation (DBS) surgery is in certain cases prescribed for Parkinson’s patients who are unresponsive to medication. This is expensive surgery, and while it can be accessed at subsidized rates in certain government hospitals, most patients are still left to incur high out-of-pocket costs.

5. Caregiver Costs
Long-term Care Requirements: Parkinson’s is usually accompanied by physical and cognitive impairments necessitating long-term care. Working caregivers will lose income because they may need to take time off work or adjust their work schedule, resulting in lost income. Families usually hire professional attendants or caregivers at an added expense.

Caregiver Training and Support Services: Training and education are necessary for workers and caregivers, as well as families, in order to manage caregiving for a person with Parkinson’s disease. This could include expenses for caregiving workshops, respite care, or other support services.

6. Social and Economic Impact
Loss of Productivity: Parkinson’s disease may affect the ability of a person to work, leading to reduced productivity and lost wages. With progressive disease, many individuals will be forced into retirement from work, resulting in direct economic costs to the individual and his/her family.

Indirect Costs: The effect of Parkinson’s disease on the patient’s family may be substantial, including economic burden resulting from lost income from the patient and potentially the caregiver, as well as out-of-pocket expenses for medical treatment.

7. Mental Health Treatment Costs
Depression and Cognitive Decline: Parkinson’s disease can potentially lead to severe psychological issues, including depression, anxiety, and cognitive impairment. These conditions are typically addressed with additional drugs and therapy, increasing the healthcare cost.

Psychosocial Support: Patients and their families may also require counseling, support groups, or other psychiatric interventions, all adding up to the overall cost.

8. Access to Specialized Care and Remote Areas
Limited Availability of Care in Rural Areas: The majority of the specialized Parkinson’s treatment facilities and neurologists are located in cities. Rural and remote patients typically need to travel great distances, pay additional transportation and accommodation charges, and may have trouble receiving timely care.

Healthcare Disparities: The disparity between private and public healthcare systems in India raises the cost of care. While public healthcare centers offer treatments at lower rates, the quality of treatment may not be good enough for controlling a complex disease like Parkinson’s. Hence, the majority of individuals need to receive treatment in private hospitals, which are very expensive.

9. Insurance Coverage and Out-of-Pocket Expenses
Limited Coverage: Although health insurance is becoming more prevalent in India, most insurance policies may not pay for all the costs of managing Parkinson’s disease, particularly long-term care, therapies, or surgery like deep brain stimulation.

Out-of-Pocket Expenses: Families and patients are usually asked to cover the bulk of the expense of Parkinson’s disease as out-of-pocket expenses, which mainly include drugs, therapies, and non-covered elective procedures.

10. Research and Awareness Costs
Lack of Awareness: Due to an absence of overall awareness about Parkinson’s disease among Indians, many patients get delayed diagnoses during the advanced stages of the disease, leading to higher costs for more expensive treatments and morbidity. Ongoing education and awareness are necessitated to reduce delayed diagnoses and improve early interventions.

Research Expenditure: Since research on Parkinson’s disease is still being carried out, investment in Parkinson’s research in India is meager. Additional research investment would likely lower health costs in the long run by increasing early detection activities, treatment channels, and models of care.

Conclusion
Parkinson’s disease is conducive to huge healthcare expenditure in India by charging diagnosis expenses, long-term drug consumption, physiotherapy, hospitalization, caregiver facilities, and mental therapy. The cost burden is amplified by limited availability of specialized services in rural populations, the outrageous expense of therapies and treatment, and patient and family out-of-pocket expenditures. To mitigate such expenses, expanded access to cheaper care, augmented public education, better insurance benefits, and more research funding for the development of treatment and management methods are necessary.
The economic cost of managing Parkinson’s disease (PD) in India is high, considering that the country is faced with an increasing prevalence of neurological disorders due to its aging population and shifting lifestyle determinants. Parkinson’s disease, being a chronic and progressive disorder affecting motor and non-motor functions, has direct and indirect economic burdens to patients, families, and the healthcare system. The following are the significant economic impacts of managing Parkinson’s disease in India:

1. Direct Medical Costs
Parkinson’s disease is a long-term illness, and treatment requires ongoing management with doctors’ consultations, drugs, tests, physiotherapy, and even operations. Direct medical costs in managing Parkinson’s disease may be quite high, particularly for those patients with late stages of the illness.

Medications: The expense of medication such as levodopa, dopamine agonists, MAO-B blockers and other medication employed to regulate the motor symptoms constitutes a critical element of therapy. These medications could be on for life with the need of tapering down dosages depending upon the progress of the illness. The price of these drugs in India could become a source of great expense to the majority of individuals, particularly those that do not benefit from insurance cover or subsidised care.

Medical Consults: Patients with Parkinson’s disease normally have to see neurologists, movement disorder specialists, and other physicians periodically. Charges for consultation can add up in the long run, especially if there are no low-cost public healthcare centers.

Diagnostic and Monitoring Tests: Clinical diagnosis establishes Parkinson’s disease, but some patients may require neuroimaging or other investigations to rule out other conditions and monitor disease progression. These diagnostic tests are expensive, especially in private health facilities.

Therapies: Physiotherapy, occupational therapy, and speech therapy are usually prescribed to patients with Parkinson’s disease to manage the motor symptoms, enhance mobility, and enhance communication. The therapies can be costly, especially if treatment is required long-term.

2. Surgical Interventions
For non-responders to medication, Deep Brain Stimulation (DBS) surgery may be recommended. The procedure, which is implanting a device to regulate abnormal brain activity, is a costly treatment. While DBS can have a dramatic effect on symptoms in some patients, it is costly, and the expense may be out of reach for many in India. In addition, post-operative visits and follow-ups add to the total cost.

3. Indirect Costs
Indirect economic cost refers to the lost productivity and additional costs incurred by caregivers and families of individuals with Parkinson’s disease. They typically contribute a significant portion of the disease’s economic cost.

Loss of Productivity: Patients with Parkinson’s disease may have difficulty continuing to work as the disease progresses. This can result in lost earnings through premature retirement, less than full-time work, or total disability. Loss of earnings can cause financial hardship for many, especially if they are primary breadwinners.

Caregiver Expenses: Parkinson’s disease often requires long term care, which can emotionally and economically drain families. Caregivers might need to reduce working hours or leave employment altogether in order to care for the patient. This results in lost income, increased stress, and potential long term financial hardship for families.

Social Support and Family Resources: Long-term care needs and activity of daily living (e.g., dressing, eating, mobility) support require relatives to devote plenty of time and resources on their care. They could otherwise expend such resources or time on school or saving it but divert this to care.
4. Impact on Healthcare System
The increasing cases of Parkinson’s disease are exerting pressure on India’s health system. With the aging population and growing cases of Parkinson’s disease, the demand for medical doctors, infrastructure, and resources dedicated to neurological care is greater. This exertion of pressure on both the public and private health systems leads to increased waiting times, reduced access to specialist services, and an overall increase in the cost of health.

Public Healthcare: Despite having an enormous public healthcare system in India, specialized treatment for Parkinson’s disease is not readily available, particularly in rural areas. The government must put more money into expanding neurology departments and providing quality, affordable treatment for Parkinson’s patients.

Insurance Cover: The majority of Indian patients do not have adequate health insurance cover, and hence the economic cost of management of Parkinson’s disease becomes still more onerous. Out-of-pocket expenses towards medical care, medication, and therapy may land families in economic difficulty. Government subsidies and improved coverage under insurance are needed for therapies of Parkinson’s disease.

5. Long-Term Economic Burden
As Parkinson’s disease is a chronic and progressive disorder, the economic burden on families and society is amplified day by day. The patients may have severe disability in the long term, leading to increased healthcare costs, more intensive treatment, and greater comorbidity (e.g., depression, dementia, and cardiovascular diseases), further escalating the costs.

Extended Care Cost: During advanced stages of the disease, patients may require twenty-four-hour care in skilled long-term care facilities or home health centers, a very costly scenario. Families usually face additional burden as they have to foot the bill for extended care provisions.

Dementia and Cognitive Decline: The vast majority of patients with progressive Parkinson’s disease ultimately develop Parkinson’s disease dementia (PDD), which significantly increases the level of care. The cost of managing cognitive decline, as well as other resultant medical complications, contributes to the long-term societal cost.

6. Economic Impact on Society
Social Security and Welfare Programs: Because of the limited insurance benefits and financial aid for patients suffering from Parkinson’s disease in India, there is a growing need for government action to ensure access to low-cost care. Welfare programs for patients with Parkinson’s disease would take the economic strain off families, but these are presently few and far between.

Research and Innovation: It could reduce long-term health spending by investing in R&D of cheap cures and technologies for Parkinson’s disease. However, the absence of substantial public investment in neurological disorders in India limits the scale and size of such initiatives. Increased government and private investment in this area could reduce the total economic burden of Parkinson’s disease through increased early detection, more effective treatments, and prevention.

7. Awareness and Education Role
Improved awareness and education about Parkinson’s disease can even have an economic effect. It can avoid complications if diagnosed in an early phase and treated appropriately, reducing the need for more invasive procedures, and improving patients’ quality of life without imposing such a huge burden on families. Support and advocacy groups such as Parkinson’s Disease and Movement Disorder Society (PDMDS) and Parkinson’s Foundation of India are likely to assist in efforts at widening the awareness base and fostering research that will minimize the economic burden in the long run.

Conclusion
Parkinson’s disease management in India has significant economic implications for patients as well as the broader healthcare system. The direct costs of the treatment, together with the indirect costs of lost productivity and caregiving, place a significant burden on families. The economic burden of Parkinson’s disease is projected to grow with the aging population and increasing incidence of neurological conditions. In order to tackle these economic challenges, there must be enhanced accessibility of affordable healthcare, increased insurance coverage, and an increase in research and public health education in India to support early detection and treatment of Parkinson’s disease.


The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts